相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines
Ruo-Chan Chen et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Reduction of Advanced-Glycation End Products Levels and Inhibition of RAGE Signaling Decreases Rat Vascular Calcification Induced by Diabetes
Mathieu R. Brodeur et al.
PLOS ONE (2014)
Soluble receptor for advanced glycation end products and risk of liver cancer
Kristin A. Moy et al.
HEPATOLOGY (2013)
Contributory Role of Five Common Polymorphisms of RAGE and APE1 Genes in Lung Cancer among Han Chinese
Hongming Pan et al.
PLOS ONE (2013)
Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy
Oliver J. Stoetzer et al.
TUMOR BIOLOGY (2013)
Regulatory T cells ameliorate cardiac remodeling after myocardial infarction
Ting-Ting Tang et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
The Associations of Advanced Glycation End Products and Its Soluble Receptor with Pancreatic Cancer Risk: A Case-Control Study within the Prospective EPIC Cohort
Verena A. Grote et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
S100P: a novel therapeutic target for cancer
Thiruvengadam Arumugam et al.
AMINO ACIDS (2011)
Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
Ravichandran Ramasamy et al.
YEAR IN DIABETES AND OBESITY (2011)
Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics
Jack Bowden et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products, and Risk of Colorectal Cancer
Li Jiao et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Evidence That Serum Levels of the Soluble Receptor for Advanced Glycation End Products Are Inversely Associated with Pancreatic Cancer Risk: A Prospective Study
Li Jiao et al.
CANCER RESEARCH (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer
Tomas Krechler et al.
CLINICAL BIOCHEMISTRY (2010)
Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer
R. Jing et al.
NEOPLASMA (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Glyoxalase I Glu111Ala Polymorphism in Patients with Breast Cancer
Alexandra Germanova et al.
CANCER INVESTIGATION (2009)
The receptor RAGE: Bridging inflammation and cancer
Astrid Riehl et al.
CELL COMMUNICATION AND SIGNALING (2009)
RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
Louis J. Sparvero et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes
Kazuo Nakamura et al.
MICROVASCULAR RESEARCH (2008)
Receptor for advanced glycation end products (RAGE) -: Soluble form (sRAGE) and gene polymorphisms in patients with breast cancer
Petra Tesarova et al.
CANCER INVESTIGATION (2007)
Random-effects model for meta-analysis of clinical trials: An update
Rebecca DerSimonian et al.
CONTEMPORARY CLINICAL TRIALS (2007)
RAGE and RAGE ligands in cancer
Craig D. Logsdon et al.
CURRENT MOLECULAR MEDICINE (2007)
Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects
Sho-ichi Yamagishi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
分享论文
